VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
Product Specifications
CAS Number
1209002-43-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
708.27
Molecular Formula
C34H42ClN9O4S
Notes
Research use only, not for human use.
Receptor
CDK
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx348577-01 50 µL
Fc receptor-like protein 5 (FCRL5) Antibody (FITC)
Sign In for Pricing
View Details 
abx348577-02 100 µL
Fc receptor-like protein 5 (FCRL5) Antibody (FITC)
Sign In for Pricing
View Details 
abx348577-03 200 µL
Fc receptor-like protein 5 (FCRL5) Antibody (FITC)
Sign In for Pricing
View Details abx348577-04 1 mL
Fc receptor-like protein 5 (FCRL5) Antibody (FITC)
Sign In for Pricing
View Details 
491800 100 µL
SKIV2L (ATP-dependent Helicase SKIV2L2, Superkiller Viralicidic Activity 2-like (S. Cerevisiae) )
Sign In for Pricing
View Details